Response to fulvestrant in heavily pretreated postmenopausal women:a single-center experience Sandra FrancoAlejandra PerezCharles L. Vogel OriginalPaper Pages: 103 - 108
Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis Harry M. LightfootAmy LarkWilliam G. Cance OriginalPaper Pages: 109 - 116
Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program J. Y. PiergaP. FumoleauJ. C. Barats OriginalPaper Pages: 117 - 129
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas Darrell L. EllsworthRachel E. EllsworthCraig D. Shriver OriginalPaper Pages: 131 - 139
Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma Wan-ching YenRene Y. PrudenteWilliam W. Lamph OriginalPaper Pages: 141 - 148
Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications William F. AndersonKenneth C. ChuSusan S. Devesa OriginalPaper Pages: 149 - 159
Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis Joan E. CunninghamWilliam M. Butler OriginalPaper Pages: 161 - 176
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India Suresh HedauNeeraj JainBhudev C. Das OriginalPaper Pages: 177 - 186
A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer Nicole Hébert-croteauCarolyn R. FreemanJacques Brisson OriginalPaper Pages: 187 - 196